More employers are requiring weigh-ins, app tracking and health coaching before approving GLP-1s for losing weight—or ...
GLP-1 drugs are now friendlier to needle-phobes. But do the pills still work?
Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences"), a commercial-stage biopharmaceutical company focused on discovering and developing innovative therapies for metabolic diseases, today ...
So, how does Victoza compare to other GLP-1 medications, including semaglutide or tirzepatide? Here’s what you need to know ...
Eli Lilly just released impressive study results for retatrutide, an investigational weight loss drug that targets three ...
Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide), today announced results demonstrating that women with ...
Full results from two Lilly trials of the novel triple hormone receptor agonist show reductions in A1c, osteoarthritis knee pain, and obstructive sleep apnea.
According to Mochi Health, more than half of its patients lose at least 10% of their body weight within the first six months, ...
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded ...
A new triple hormone receptor agonist for type 2 diabetes could lower blood pressure and body weight. The clinical results ...